The effect of Vitagnos tablets on the function of polycystic ovaries

Phase 3

Recruiting

Conditions: polycystic ovary syndrome.
Polycystic ovarian syndrome
E28.2

Registration Number: IRCT20200831048569N1

Lead Sponsor: Gonabad University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Female

Target Recruitment: 60

Inclusion Criteria

Age 18 to 35 years
Having written consent to participate in the study
Infertility is known to cause polycystic ovary syndrome and rule out other causes of infertility
Ultrasound-confirmed polycystic ovaries along with another Rotterdam criteria
No other androgenic disorders such as adrenal hyperplasia or androgen-producing tumor
Manifestations of hyperandrogenism (high testosterone)
No diseases such as: hypothyroidism or hyperthyroidism, hyperprolactinemia, kidney, heart, liver, bone diseases, pituitary tumor, cancer and diabetes
Do not take infertility drugs or any other hormonal drugs in the last three months
Body mass index 18 to 35
Hypersensitivity to food and drugs such as lactose, letrozole and vitagnus

Exclusion Criteria

Breastfeeding
Smoking and drugse
Stressful events in the last three months
Previous surgery on one or both ovaries
Taking haloperidol

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of follicles. Timepoint: Before the intervention and 1/5 month after the intervention. Method of measurement: Sonography.;Follicle size. Timepoint: Before the intervention and 1/5 month after the intervention. Method of measurement: Sonography.;Endometrial thickness. Timepoint: Before the intervention and 1/5 month after the intervention. Method of measurement: Sonography.;Fertility rate. Timepoint: Before intervention and 2 months after intervention. Method of measurement: BHCG test.

Secondary Outcome Measures

Name	Time	Method
Improve ovarian function. Timepoint: After the intervention. Method of measurement: sonography.;Side effects. Timepoint: During and after the intervention. Method of measurement: check list.